These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32860375)

  • 1. CIP2A expression in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue mıcroarray study.
    Celikden SG; Baspinar S; Ozturk SA; Karaibrahimoglu A
    Malays J Pathol; 2020 Aug; 42(2):227-236. PubMed ID: 32860375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relation of beclin 1 and bcl-2 expressions in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue microarray study.
    Baspinar S; Bircan S; Orhan H; Kapucuoglu N; Bozkurt KK
    Pathol Res Pract; 2014 Jul; 210(7):412-8. PubMed ID: 24690321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of NGF, GDNF and MMP-9 in prostate carcinoma.
    Baspinar S; Bircan S; Ciris M; Karahan N; Bozkurt KK
    Pathol Res Pract; 2017 May; 213(5):483-489. PubMed ID: 28237042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
    Zeng L; Rowland RG; Lele SM; Kyprianou N
    Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical profiles of claudin-3 in primary and metastatic prostatic adenocarcinoma.
    Bartholow TL; Chandran UR; Becich MJ; Parwani AV
    Diagn Pathol; 2011 Jan; 6():12. PubMed ID: 21255442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of prostate tumour overexpressed 1 (PTOV1) in atypical adenomatous hyperplasia (AAH) of the prostate: additional evidence linking (AAH) to adenocarcinoma.
    Mazzucchelli R; Scarpelli M; Barbisan F; Santinelli A; Lopez-Beltran A; Cheng L; Montironi R
    Cell Oncol (Dordr); 2013 Feb; 36(1):37-42. PubMed ID: 23132460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
    Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
    J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAGI-2 in prostate cancer: an immunohistochemical study.
    Goldstein J; Borowsky AD; Goyal R; Roland JT; Arnold SA; Gellert LL; Clark PE; Hameed O; Giannico GA
    Hum Pathol; 2016 Jun; 52():83-91. PubMed ID: 26980016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
    Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG
    Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-expression of TLR-9 and MMP-13 is associated with the degree of tumour differentiation in prostate cancer.
    Kalantari E; Abolhasani M; Roudi R; Farajollahi MM; Farhad S; Madjd Z; Askarian-Amiri S; Mohsenzadegan M
    Int J Exp Pathol; 2019 Apr; 100(2):123-132. PubMed ID: 31090157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
    Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
    Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of PDX-1 in prostate cancer, prostatic intraepithelial neoplasia and benign prostatic tissue.
    Jonmarker S; Glaessgen A; Culp WD; Pisa P; Lewensohn R; Ekman P; Valdman A; Egevad L
    APMIS; 2008 Jun; 116(6):491-8. PubMed ID: 18754323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Snail1 is over-expressed in prostate cancer.
    Heebøll S; Borre M; Ottosen PD; Dyrskjøt L; Orntoft TF; Tørring N
    APMIS; 2009 Mar; 117(3):196-204. PubMed ID: 19245592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of interphase fluorescence in situ hybridization in prostate needle biopsy specimens with isolated high-grade prostatic intraepithelial neoplasia as a predictor of prostate adenocarcinoma on follow-up biopsy.
    Bastacky S; Cieply K; Sherer C; Dhir R; Epstein JI
    Hum Pathol; 2004 Mar; 35(3):281-9. PubMed ID: 15017583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression analysis of putative stem cell markers in human benign and malignant prostate.
    Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
    Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAGI-2 Is a Sensitive and Specific Marker of Prostatic Adenocarcinoma:  A Comparison With AMACR.
    Goldstein J; Goyal R; Roland JT; Gellert LL; Clark PE; Hameed O; Giannico GA
    Am J Clin Pathol; 2016 Sep; 146(3):294-302. PubMed ID: 27543977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of estrogen receptor-B ( ER-B ) in bengin and malignant prostatic epithelial cells and its correlation with the clinico-pathological features.
    Gabal SM; Habib FM; Helmy DO; Ibrahim MF
    J Egypt Natl Canc Inst; 2007 Dec; 19(4):239-48. PubMed ID: 19672287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.
    He H; Osunkoya AO; Carver P; Falzarano S; Klein E; Magi-Galluzzi C; Zhou M
    BJU Int; 2012 Dec; 110(11 Pt B):E751-5. PubMed ID: 23046279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of MST4, STK25 and PDCD10 between benign prostatic hyperplasia and prostate cancer.
    Zhang H; Ma X; Peng S; Nan X; Zhao H
    Int J Clin Exp Pathol; 2014; 7(11):8105-11. PubMed ID: 25550858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CIP2A expression is increased in prostate cancer.
    Vaarala MH; Väisänen MR; Ristimäki A
    J Exp Clin Cancer Res; 2010 Oct; 29(1):136. PubMed ID: 20964854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.